Assessment of phsychological well-being and prevalence of depressive symptoms amoung young adults with type-1 diabetes mellitus

Anu Anna Jacob, Divya Deodhar


Background: Depression in adolescents and young adults with type-1 diabetes mellitus has been associated with poor glycemic control and recurrent hospitalizations. The World Health Organization-Five Well- being index (WHO-5) is a simple, short and positively worded screening method to assess the level of emotional well-being and has been validated for use in adolescents with type-1 diabetes mellitus. Aims and objectives to assess the psychological well-being in adolescents and young adults with type-1 diabetes mellitus using the WHO-5 well-being index. To estimate the prevalence of symptoms of depression in type-1 diabetes mellitus using the major (ICD-10) depression inventory (MDI-ICD-10) of the psychiatric research unit.

Methods: Study was a prospective study. Cases were patients with type-1 diabetes mellitus who attended the “Juvenile Diabetic Club” in CMC Ludhiana consisting of children and adolescents. Controls were healthy age matched adolescents within the family of the patients. Informed consent was taken, and they were asked to fill up the structured WHO-5 Well-being index (version 1998) questionnaire and the WHO-Major (ICD-10) Depression Inventory (MDI-ICD-10) questionnaire.

Results: 36 patients were chosen for the study. There were 20 boys and 16 girls. 12 (33.3%) patients (diabetic group) had scores indicating poor well- being. P value is 0.0455, statistically significant. Among the healthy control (non- diabetic group), all of them had a scores suggesting good well- being.

Conclusions: 33% of the diabetic children are depressed compared to the non-diabetic candidates in whom none are depressed.


Asterion, Approach to posterior cranial fossa, Mastoid process, Transverse sinus

Full Text:



Davidson's Principles and Practice of Medicine, International Edition; 2005.

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20(7):1183-97.

Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2003;26:3160-67.

Harrison’s, Book of Medicine, Volnme- II, 2005.

Tseung J. Robbins and Cotran pathologic basis of disease. 7th ed. 2005.

Mathis D, Vence L, Benoist C. Beta-cell death during progression to diabetes. Nature. 2001;414.

Pietropaolo M, Eisenbarth GS. Autoantibodies in human diabetes. InMolecular Pathology of Type 1 Diabetes mellitus. 2001;4:252-282).

McDevitt H: The role of MHC class II molecules in the pathogenesis and prevention of type 1 diabetes. Adv Exp Med Biol. 2001:490.

Jaeckel E, Manns M, Von Herrath M. Viruses and diabetes. Ann N Y Acad Sci. 2002:958.

Swash M, Glynn M. Hutchison's clinical methods: An integrated approach to clinical practice. 22nd ed 2007.

Alagappan R. Manual of practical medicine. JP Medical Ltd; 2014.

Engum A, Mykletun A, Midthjell K, Holen, Dahl A. A large Population-based study of sociodemographic, lifestyle, and clinical factors associated with the depression in type 1 and type 2 diabetes Mellitus. Diabetes Care; 2005.

Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes. Diabetes care. 2001;24(6):1069-78.

Lustman PJ, Anderson RJ, Freedland KE, De Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes care. 2000;23(7):934-42.

De Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosomatic Medic. 2001;63(4):619-30.

Fisher L, Chesla CA, Mullan JT, Skaff MM, Kanter RA. Contributors to depression in Latino and European-American patients with type 2 diabetes. Diabetes care. 2001;24(10):1751-7.

Everson SA, Maty SC, Lynch JW, Kaplan GA. Epidemiologic evidence for the relation between socioeconomic status and depression, obesity, and diabetes. J Psychosomatic Res. 2002;53(4):891-5.

Peyrot M, Rubin RR. Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes care. 1997;20(4):585-90.

Katon W, Von Korff M, Ciechanowski P, Russo J, Lin E, Simon G, et al. Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes care. 2004;27(4):914-20.

Egede LE, Zheng D. Independent factors associated with major depressive disorder in a national sample of individuals with diabetes. Diabetes care. 2003;26(1):104-11.

Ryerson B, Tierney EF, Thompson TJ, Engelgau MM, Wang J, Gregg EW, Geiss LS. Excess physical limitations among adults with diabetes in the US population, 1997-1999. Dia care. 2003;26(1):206-10.

Thomas J, Jones G, Scarinci I, Brantley P. A descriptive and comparative study of the prevalence of depressive and anxiety disorders in low-income adults with type 2 diabetes and other chronic illnesses. Diabetes care. 2003;26(8):2311-7.

Dantzer C, Swendsen J, Maurice-Tison S, Salamon R. Anxiety and depression in juvenile diabetes: a critical review. Clinic Psychol Review. 2003;23(6):787-800.

Hood KK, Huestis S, Maher A, Butler D, Volkening L, Laffel LM. Depressive symptoms in children and adolescents with type 1 diabetes. Diabetes care. 2006;29(6):1389.

Lawrence JM, Standiford DA, Loots B, Klingensmith GJ, Williams DE, Ruggiero A, et al. Prevalence and correlates of depressed mood among youth with diabetes: the SEARCH for Diabetes in Youth study. Pediatrics. 2006;117(4):1348-58.

Hassan K, Loar R, Anderson BJ, Heptulla RA. The role of socioeconomic status, depression, quality of life, and glycemic control in type 1 diabetes mellitus. J pediatrics. 2006;149(4):526-31.

Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, Deeb L, Grey M, Anderson B, Holzmeister LA, Clark N. Care of children and adolescents with type 1 diabetes. Diabetes care. 2005;28(1):186-212.

Anderson RJ, Freedland KE, Clouse RE, Lustman PJ: The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24.

Videbech P, Ravnkilde B, Kristensen S, Egander A, Clemmensen K, Rasmussen NA, et al. The Danish PET/depression project: poor verbal fluency performance despite normal prefrontal activation in patients with major depression. Psy Res: Neuroimag. 2003;123(1):49-63.

Hammar Å, Lund A, Hugdahl K. Long-lasting cognitive impairment in unipolar major depression: a 6-month follow-up study. Psychiatry Res. 2003;118(2):189-96.

Portella MJ, Marcos T, Rami L, Navarro V, Gasto C, Salamero M. Residual cognitive impairment in late‐life depression after a 12‐month period follow‐up. Inter J Geria Psy. 2003;18(7):571-6.

Gallassi R, Morreale A, Pagni P. The relationship between depression and cognition. Archives Gerontol Geriatrics. 2001;33:163-71.

Lawrie SM, Machale SM, Cavanagh JT, O’Carrol RE, Goodwin GM. The Difference in pattern of motor and cognitive function in chronic fatigue syndrome and severe depressive illness. Psychol Med. 2000;30:433-442.

Elderkin-Thompson V, Kumanr A, Billker WB, Dunkinn JJ, Mintz J, Moberg PJ, Mesholam RI, Gur RE: Neurological Deficit among patients with late- onset major depression. Arch Clin Neuro-psychol. 2003;18:529-49.

Mauricio Tohen. Olanzapine Versus Placebo in the Treatment of Adolescents with Bipolar Mania. The Americ J Psychiatr. 2007:164.

Susman-Stillman A, Hyson DM, Anderson FS, Colllins WA. Adolescent psychosocial development and adherence to treatment for insulin-dependent diabetes mellitus, 1997.

La Greca AM, Bearman KJ, Moore H. Peer relations of youth with pediatric conditions and health risks: Promoting social support and healthy lifestyles. J Developmental Behavioral Pediatr. 2002;23(4):271-80.

Farrell SP, Hains AA, Davies WH, Smith P, Parton E. The impact of cognitive distortions, stress, and adherence on metabolic control in youths with type 1 diabetes. J Adolescent Heal. 2004;34(6):461-7.

Kendall PC, Chansky TE. Anxiety disorders in youth: Cognitive-behavioral interventions. Allyn & Bacon;1992.

Aikens JE, Wallander JL, Bell DS, Cole JA. Daily stress variability, learned resourcefulness, regimen adherence, and metabolic control in type I diabetes mellitus: evaluation of a path model. J Consulting Clinical Psychol. 1992;60(1):113.

Löwe B, Spitzer RL, Gräfe K, Kroenke K, Quenter A, Zipfel S, Buchholz C, Witte S, Herzog W. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians’ diagnoses. J Affective Dis. 2004;78(2):131-40.

Awata S, Bech P, Yoshida S, Hirai M, Suzuki S, Yamashita M, Ohara A, Hinokio Y, Matsuoka H, Oka Y. Reliability and validity of the Japanese version of the world health organization‐five well‐being index in the context of detecting depression in diabetic patients. Psych Clini Neurosci. 2007;61(1):112-9.